Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jorgenson

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 8, 2019
A targeted fungal prophylaxis protocol with static dosed fluconazole significantly reduces invasive fungal infection after liver transplantationMargaret R Jorgenson, Jillian L Descourouez, Nicholas A Marka, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 21, 2019
Risk of opportunistic infection in kidney transplant recipients with cytomegalovirus infection and associated outcomesMargaret R Jorgenson, Jillian L Descourouez, Brianna Cardinale, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 5, 2021
Risk factors for progression from low level BK dnaemia to unfavorable outcomes after BK management via immunosuppressive reductionAbish Kharel, Arjang Djamali, Margaret R Jorgenson, et al.
Clinical Transplantation|November 10, 2022
Seasonal variation of cytomegalovirus disease in kidney transplant recipientsMargaret R Jorgenson, Hanna L Kleiboeker, Brad C Astor, et al.
Clinical Transplantation|July 15, 2021
A pilot study of an intensified ganciclovir dosing strategy for treatment of cytomegalovirus disease in kidney and/or pancreas transplant recipientsMargaret R Jorgenson, Jillian L Descourouez, Glen E Leverson, et al.
The Annals of Pharmacotherapy|August 29, 2017
Vancomycin Prophylaxis for Prevention of Clostridium difficile Infection Recurrence in Renal Transplant PatientsLindsey E Splinter, Luiza Kerstenetzky, Margaret R Jorgenson, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 29, 2021
Cytomegalovirus nephritis in kidney transplant recipients: Epidemiology and outcomes of an uncommon diagnosisKurtis J Swanson, Arjang Djamali, Margaret R Jorgenson, et al.
Clinical Transplantation|September 4, 2024
Cytomegalovirus Post-Prophylaxis Surveillance in High-Risk Kidney and Liver Recipients Prevents CMV End-Organ Disease and Ganciclovir-ResistanceMargaret R Jorgenson, Ethan Meyer, Glen E Leverson, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 15, 2021
Impact and outcomes of primary cytomegalovirus disease in seronegative abdominal solid organ transplant recipients of cytomegalovirus unexposed donors (D-/R-)Margaret R Jorgenson, Jillian L Descourouez, Dou-Yan Yang, et al.
The Annals of Pharmacotherapy|April 23, 2019
Epidemiology, Risk Factors, and Outcomes After Early Posttransplant <i>Clostridiodes difficile</i> Infection in Renal Transplant RecipientsMargaret R Jorgenson, Jillian L Descourouez, Dou-Yan Yang, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 8, 2019
A targeted fungal prophylaxis protocol with static dosed fluconazole significantly reduces invasive fungal infection after liver transplantationMargaret R Jorgenson, Jillian L Descourouez, Nicholas A Marka, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 21, 2019
Risk of opportunistic infection in kidney transplant recipients with cytomegalovirus infection and associated outcomesMargaret R Jorgenson, Jillian L Descourouez, Brianna Cardinale, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 5, 2021
Risk factors for progression from low level BK dnaemia to unfavorable outcomes after BK management via immunosuppressive reductionAbish Kharel, Arjang Djamali, Margaret R Jorgenson, et al.
Clinical Transplantation|November 10, 2022
Seasonal variation of cytomegalovirus disease in kidney transplant recipientsMargaret R Jorgenson, Hanna L Kleiboeker, Brad C Astor, et al.
Clinical Transplantation|July 15, 2021
A pilot study of an intensified ganciclovir dosing strategy for treatment of cytomegalovirus disease in kidney and/or pancreas transplant recipientsMargaret R Jorgenson, Jillian L Descourouez, Glen E Leverson, et al.
The Annals of Pharmacotherapy|August 29, 2017
Vancomycin Prophylaxis for Prevention of Clostridium difficile Infection Recurrence in Renal Transplant PatientsLindsey E Splinter, Luiza Kerstenetzky, Margaret R Jorgenson, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 29, 2021
Cytomegalovirus nephritis in kidney transplant recipients: Epidemiology and outcomes of an uncommon diagnosisKurtis J Swanson, Arjang Djamali, Margaret R Jorgenson, et al.
Clinical Transplantation|September 4, 2024
Cytomegalovirus Post-Prophylaxis Surveillance in High-Risk Kidney and Liver Recipients Prevents CMV End-Organ Disease and Ganciclovir-ResistanceMargaret R Jorgenson, Ethan Meyer, Glen E Leverson, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 15, 2021
Impact and outcomes of primary cytomegalovirus disease in seronegative abdominal solid organ transplant recipients of cytomegalovirus unexposed donors (D-/R-)Margaret R Jorgenson, Jillian L Descourouez, Dou-Yan Yang, et al.
The Annals of Pharmacotherapy|April 23, 2019
Epidemiology, Risk Factors, and Outcomes After Early Posttransplant <i>Clostridiodes difficile</i> Infection in Renal Transplant RecipientsMargaret R Jorgenson, Jillian L Descourouez, Dou-Yan Yang, et al.
Pageof 8